Derek J. Maetzold - Pres. & Chief Exec. Officer, Director at Castle Biosciences Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. & Chief Exec. Officer, Director
Stock Symbol
CSTL on Nasdaq
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

Derek J. Maetzold - trading volume in the past year for Castle Biosciences Inc

Holdings reported by Derek J. Maetzold for Castle Biosciences Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 123K $3.73M $30.32 Sep 11, 2024 By DJM Grantor Retained Annuity Trust No. 5
Common Stock 97.6K $2.96M $30.32 Sep 11, 2024 Direct
Restricted Stock Units 124K $2.66M $21.41 Mar 4, 2024 Direct Common Stock
Common Stock 79.7K $2.42M $30.32 Sep 11, 2024 By The Maetzold Descendants 2020 Trust
Common Stock 68.6K $2.08M $30.32 Sep 11, 2024 By Derek Maetzold 2020 Irrevocable Trust
Performance-Based Stock Unit 67K $1.8M $26.83 Aug 9, 2024 Direct Common Stock
Common Stock 26.1K $792K $30.32 Sep 11, 2024 By DJM Grantor Retained Annuity Trust No. 6
Common Stock 7.66K $232K $30.32 Sep 11, 2024 By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk
Common Stock 7.65K $232K $30.32 Sep 11, 2024 By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold
Common Stock 7.65K $232K $30.32 Sep 11, 2024 By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold
Common Stock 7.65K $232K $30.32 Sep 11, 2024 By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold
Stock option (right to buy) 0 $0 $3.72 Mar 5, 2024 Direct Common Stock

Transactions reported by Derek J. Maetzold for Castle Biosciences Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.